- Report
- October 2024
- 190 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 150 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- May 2024
- 70 Pages
United States
From €3595EUR$3,950USD£3,082GBP
- Report
- August 2023
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2023
- 117 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Book
- August 2014
- 376 Pages
The Dried Blood Spot (DBS) market is a subset of the coagulation and hemostasis testing market. DBS is a method of collecting and testing blood samples that involves collecting a small amount of blood on a filter paper card. This method is used to test for a variety of conditions, including hemophilia, thrombophilia, and other bleeding disorders. DBS is a cost-effective and convenient alternative to traditional venipuncture, as it requires less blood and can be collected in a variety of settings.
The DBS market is expected to grow due to the increasing prevalence of bleeding disorders, the growing demand for point-of-care testing, and the increasing adoption of DBS technology. Additionally, the development of new technologies and the increasing availability of DBS kits are expected to drive the market growth.
Some of the major companies in the DBS market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Grifols. Show Less Read more